Research ArticleArticle
Rheumatoid Arthritis Disease-modifying Antirheumatic Drug Intervention and Utilization Study: Safety and Etanercept Utilization Analyses from the RADIUS 1 and RADIUS 2 Registries
Allan Gibofsky, William R. Palmer, Edward C. Keystone, Michael H. Schiff, Jingyuan Feng, Peter McCroskery, Scott W. Baumgartner and Joseph A. Markenson
The Journal of Rheumatology October 2010, jrheum.100347; DOI: https://doi.org/10.3899/jrheum.100347
Allan Gibofsky
William R. Palmer
Edward C. Keystone
Michael H. Schiff
Jingyuan Feng
Peter McCroskery
Scott W. Baumgartner
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Rheumatoid Arthritis Disease-modifying Antirheumatic Drug Intervention and Utilization Study: Safety and Etanercept Utilization Analyses from the RADIUS 1 and RADIUS 2 Registries
Allan Gibofsky, William R. Palmer, Edward C. Keystone, Michael H. Schiff, Jingyuan Feng, Peter McCroskery, Scott W. Baumgartner, Joseph A. Markenson
The Journal of Rheumatology Oct 2010, jrheum.100347; DOI: 10.3899/jrheum.100347
Rheumatoid Arthritis Disease-modifying Antirheumatic Drug Intervention and Utilization Study: Safety and Etanercept Utilization Analyses from the RADIUS 1 and RADIUS 2 Registries
Allan Gibofsky, William R. Palmer, Edward C. Keystone, Michael H. Schiff, Jingyuan Feng, Peter McCroskery, Scott W. Baumgartner, Joseph A. Markenson
The Journal of Rheumatology Oct 2010, jrheum.100347; DOI: 10.3899/jrheum.100347